SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016350
Filing Date
2022-11-04
Accepted
2022-11-04 09:46:59
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20220930x10q.htm   iXBRL 10-Q 1173953
2 EX-31.1 imgn-20220930xex31d1.htm EX-31.1 10922
3 EX-31.2 imgn-20220930xex31d2.htm EX-31.2 10958
4 EX-32 imgn-20220930xex32.htm EX-32 10016
  Complete submission text file 0001558370-22-016350.txt   5501850

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20220930.xsd EX-101.SCH 50087
6 EX-101.CAL imgn-20220930_cal.xml EX-101.CAL 32548
7 EX-101.DEF imgn-20220930_def.xml EX-101.DEF 223574
8 EX-101.LAB imgn-20220930_lab.xml EX-101.LAB 403178
9 EX-101.PRE imgn-20220930_pre.xml EX-101.PRE 323566
53 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20220930x10q_htm.xml XML 848854
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 221360636
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences